Kirschbaum Mark - Insider Non-Derivative Transactions at Cyclacel Pharmaceuticals, Inc. (CYCC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 31, 2023, Kirschbaum Mark's relationship to Cyclacel Pharmaceuticals, Inc. (CYCC) is Officer (Chief Medical Officer), and currently has 31,200 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CYCC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kirschbaum Mark - Insider Non-Derivative Transactions of CYCC Common Stock

Kirschbaum Mark - Insider Non-Derivative Transactions at CYCC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 1, 2023	Acquisition -- (Common Stock)	31200	0	31200